Results 161 to 170 of about 86,092 (288)

Immune checkpoint inhibitor cardiomyotoxicity: a case series of five patients and development of a clinical management algorithm

open access: yesInternal Medicine Journal, EarlyView.
Abstract Immune checkpoint inhibitor (ICI) therapies have revolutionised the management of a range of malignancies. However, the syndrome of ICI induced cardiomyotoxicity, also reported as triple “M” syndrome (myasthenia gravis, myositis and myocarditis) is an unfortunate severe consequence in up to 1%–2% of patients receiving ICI, with an associated ...
S. Z. Xie   +14 more
wiley   +1 more source

Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction. [PDF]

open access: yesJ Am Heart Assoc
Ohno J   +12 more
europepmc   +1 more source

Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure. [PDF]

open access: yesCell Mol Life Sci, 2023
Raffa S   +14 more
europepmc   +1 more source

Dehydration increases the density of C-receptors for ANF on rat glomerular membranes [PDF]

open access: yes, 1990
Gerbes, Alexander L.   +3 more
core   +1 more source

Clinical Prediction Model for Unsuccessful Left Bundle Branch Area Pacing

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
A clinical prediction model based on NIVCD, interventricular septal thickness, and right atrial area enables individualized estimation of unsuccessful LBBAP and may help guide procedural strategy. ABSTRACT Introduction Left bundle branch area pacing (LBBAP) has rapidly become a preferred form of cardiac physiologic pacing; however, predictors of ...
Yousaku Okubo   +13 more
wiley   +1 more source

Assessing fluid volume and determining outcomes of acute heart failure using plasma human atrial natriuretic peptide. [PDF]

open access: yesClin Exp Nephrol, 2023
Suzuki Y   +11 more
europepmc   +1 more source

Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
In persistent AF, adjunctive dominant frequency‐guided ablation after pulmonary vein isolation did not significantly improve outcomes. Limited overlap between high‐frequency sites and low‐voltage areas suggests functional–structural dissociation, while right atrial low‐voltage burden predicts recurrence.
Koji Kumagai   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy